...
首页> 外文期刊>Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research >Genetic susceptibility to renal cell carcinoma: the role of DNA double-strand break repair pathway.
【24h】

Genetic susceptibility to renal cell carcinoma: the role of DNA double-strand break repair pathway.

机译:肾细胞癌的遗传易感性:DNA双链断裂修复途径的作用。

获取原文
获取原文并翻译 | 示例

摘要

Alterations in DNA repair genes have been shown to cause a reduction in host DNA repair capacity and may influence host susceptibility to carcinogenesis. The double-strand break repair is a major DNA-repair pathway. This study tested the hypothesis that common sequence variants of the double-strand break pathway genes predispose susceptible individuals to an increased risk for renal cell carcinoma. Toward this end, we evaluated the associations of 13 single-nucleotide polymorphisms in 10 candidate genes involved in the double-strand break pathway with renal cell carcinoma risk in a population-based case-control study that included 326 Caucasian renal cell carcinoma patients and 335 controls. Using the homozygous wild type as the reference group, we observed a significantly increased renal cell carcinoma risk associated with the homozygous variant genotype of NBS1 (rs1805794; odds ratio, 2.13; 95% confidence interval (95% CI), 1.17-3.86). Carrying of at least one copy of the variant XRCC4 allele was also associated with a significantly increased risk (rs1805377; odds ratio, 1.56; 95% CI, 1.08-2.26). Importantly, in pathway analysis, compared with the reference group (1 or less adverse alleles), individuals with two (odds ratio, 1.26; 95% CI, 0.83-1.91), three (odds ratio, 1.00; 95% CI, 0.64-1.56), and more than three adverse alleles (odds ratio, 1.75; 95% CI, 1.03-2.98) were at increased risk for renal cell carcinoma with significant association in subjects carrying more than 3 adverse alleles. Results from this study provide evidence that individuals with a higher number of genetic variations in the DBS repair pathway are at an increased risk for renal cell carcinoma. These findings require further validation in independent populations.
机译:DNA修复基因的改变已显示会导致宿主DNA修复能力的降低,并可能影响宿主对致癌作用的敏感性。双链断裂修复是主要的DNA修复途径。这项研究检验了以下假设,即双链断裂途径基因的常见序列变异使易感个体容易患肾细胞癌。为此,我们在一项基于人群的病例对照研究中评估了涉及双链断裂途径的10个候选基因中13个单核苷酸多态性与肾细胞癌风险的关联,该研究包括326例白种人肾细胞癌患者和335例患者控件。使用纯合子野生型作为参考组,我们观察到与NBS1纯合子变异基因型相关的肾细胞癌风险显着增加(rs1805794;比值比为2.13; 95%置信区间(95%CI)为1.17-3.86)。携带至少一份拷贝的XRCC4等位基因也与风险显着增加有关(rs1805377;比值比为1.56; 95%CI为1.08-2.26)。重要的是,在通路分析中,与参考组(1个或更少的不良等位基因)相比,个体为两个(奇数比,1.26; 95%CI,0.83-1.91),三个(奇数比,1.00; 95%CI,0.64-)。 1.56),且携带3个以上不良等位基因的受试者中,有超过3个不良等位基因(比值比为1.75; 95%CI为1.03-2.98)患肾细胞癌的风险显着增加。这项研究的结果提供了证据,表明DBS修复途径中遗传变异数量较高的个体罹患肾细胞癌的风险增加。这些发现需要在独立人群中进一步验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号